Beta Bionics, Inc.
BBNX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001674632
In the last 90 days, Beta Bionics, Inc. insiders filed 0 open-market purchases and 11 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $752.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Beta Bionics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +102 vs. Q4 2024
- Shares held
- 41.7M
- +41.7M vs. Q4 2024
- Total value
- $508.0M
- +$508.0M vs. Q4 2024
- New holders
- 102
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 133 | $752.4M |
| Q1 2026 | 130 | $494.9M |
| Q4 2025 | 158 | $1.44B |
| Q3 2025 | 129 | $959.9M |
| Q2 2025 | 116 | $659.1M |
| Q1 2025 | 102 | $508.0M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Beta Bionics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 3,901,599 | $47.3M | 0.01% | +3,901,599 | New |
| Eventide Asset Management, LLC | 4,928,019 | $60.3M | 1.20% | +4,928,019 | New |